517920-69-3Relevant articles and documents
Aromatic-ring-containing compound, preparation method thereof, pharmaceutical composition and application thereof
-
Paragraph 0472-0476, (2018/08/03)
The invention discloses an aromatic-ring-containing compound, a preparation method thereof, a pharmaceutical composition and application. The present invention provides the aromatic-ring-containing compound represented by a formula 1, a pharmaceutically acceptable salt thereof, a stereoisomer thereof, a tautomer thereof or a solvate thereof, and the aromatic-ring-containing compound can be effectively bounded to bromodomains of BRD4, BRD3, BRD2, and BRDT in BET family to regulate transcription of downstream gene c-myc and related target genes of the c-myc so as to regulate downstream signalingpathways to play specific roles including treatment of diseases such as inflammatory diseases, cancer, and AIDS. Some of the compounds have high activity, and have good cell activity and metabolic stability, so that the compounds can be an effective drug for treating tumors.
SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF
-
Page/Page column 116-117, (2010/04/03)
The present application relates to novel substituted 5-aminopyrazoles, methods of production thereof, use thereof alone or in combinations for the treatment and/or prophylaxis of diseases and use thereof for the production of medicinal products for the treatment and/or prophylaxis of diseases.
Benzimidazole- and benzoxazole-based inhibitors of Rho kinase
Sessions, E. Hampton,Yin, Yan,Bannister, Thomas D.,Weiser, Amiee,Griffin, Evelyn,Pocas, Jennifer,Cameron, Michael D.,Ruiz, Claudia,Lin, Li,Schuerer, Stephan C.,Schroeter, Thomas,LoGrasso, Philip,Feng, Yangbo
experimental part, p. 6390 - 6393 (2009/09/06)
Inhibitors of Rho kinase have been developed based on two distinct scaffolds, benzimidazoles, and benzoxazoles. SAR studies and efforts to optimize the initial lead compounds are described. Novel selective inhibitors of ROCK-II with excellent potency in b